Medical News

RSS

FDA approves Actavis' ANDA for Telmisartan Immediate-Release Tablets

Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.

9 Jan 2014

Study shows that anticoagulant medicine appears to protect patients against stroke

Heart palpitations. Shortness of breath. Tiredness. More and more people can recognise the symptoms of atrial fibrillation, which is one of the most common types of heart disease.

9 Jan 2014

Health industry insiders analyze, predict and prescribe

Kaiser Health News checks in with former HHS chief Michael Leavitt while CQ HealthBeat details insights from another insider, Robert Laszewski.

9 Jan 2014

Responsibility increases for parents who give electronic devices as Christmas gift to kids

Smartphones, laptops, tablets and video games were happily crossed off many the wish lists of many young children and teens this Christmas. But for parents, giving children electronic devices has to be about more than just saving Christmas, it has to be about making sure kids are safe when they start getting online.

9 Jan 2014

NYSCF and ISMMS scientists successfully generate stem cell model of familial Alzheimer's disease

Scientists at The New York Stem Cell Foundation Research Institute in collaboration with scientists at the Icahn School of Medicine at Mount Sinai successfully generated a stem cell model of familial Alzheimer's disease.

8 Jan 2014

Epilepsy drug taken during pregnancy not linked with development problems for preschoolers

A new study finds that the epilepsy drug levetiracetam appears not to be associated with thinking, movement and language problems for preschool children born to mothers who took the drug during pregnancy, although the drug valproate was associated with some difficulties in preschoolers.

8 Jan 2014

Researchers develop new, safer and noninvasive diagnostic technique for ulcers

Doctors may soon be able to diagnose stomach ulcers without taking tissue samples from the stomach. Researchers from the University of Southern Denmark now report to have developed a new, safer and noninvasive diagnostic technique for ulcers.

8 Jan 2014

Hebrew University research could lead to efficient and fast-acting antidepressant drugs

The World health Organization calls depression "the leading cause of disability worldwide," causing more years of disability than cancer, HIV/AIDS, and cardiovascular and respiratory diseases combined.

8 Jan 2014

Nociceptin in brain naturally moderates effects of stress

Collaborating scientists at The Scripps Research Institute (TSRI), the National Institutes of Health (NIH) and the University of Camerino in Italy have published new findings on a system in the brain that naturally moderates the effects of stress.

8 Jan 2014

A new health insurer raises funds after rapid growth

A new health insurer is betting that it can enter a crowded, but lucrative market. In the meantime, health care stocks helped markets surge Tuesday.

8 Jan 2014

Plasma thermogram can serve as an indicator of cervical cancer

Researchers at the University of Louisville have confirmed that using the heat profile from a person's blood, called a plasma thermogram, can serve as an indicator for the presence or absence of cervical cancer, including the stage of cancer.

8 Jan 2014

Risk of serious complications higher for babies conceived by assisted reproductive therapies

A University of Adelaide study has shown that the risk of serious complications such as stillbirth, preterm birth, low birth weight and neonatal death is around twice as high for babies conceived by assisted reproductive therapies compared with naturally conceived babies.

8 Jan 2014

Working out while sick can actually do more harm than good, says professor

With the flu and cold season in full swing, kinesiology professor Karin Richards, at University of the Sciences in Philadelphia, said many people tend to ignore their symptoms to keep on track with their fitness resolutions for the New Year.

8 Jan 2014

Slower decline for patients with PARKIN-associated PD

Cognitive and motor decline may be slower in patients with early-onset Parkinson’s disease if they have PARKIN mutations, suggests an analysis of the Consortium on Risk for Early-Onset PD study.

8 Jan 2014

Long follow-up needed after acute or transient psychotic disorder diagnosis

The validity of the International Classification of Diseases-10 category of acute and transient psychotic disorders is debatable, say researchers who found that around half of patients moved to a different category within a few years.

8 Jan 2014

Support for DSM-5 mixed features specifier

Study findings uphold the value of the DSM-5 mixed features specifier of at least three depressive symptoms during a manic episode for diagnosing and classifying patients with mixed mania.

8 Jan 2014

Dementia detracts from PD patients’ life expectancy

Patients with Parkinson’s disease have an increased risk for mortality, especially if they have dementia, a meta-analysis confirms.

8 Jan 2014

Sleep disorder linked to poor nonmotor status in Parkinson’s disease

The presence of rapid eye movement sleep behavior disorder is associated with more severe nonmotor symptoms in patients with early-stage Parkinson’s disease, a study shows.

8 Jan 2014

Qosina announces addition of new Control Stroke Syringes

Qosina is pleased to announce the addition of five new Control Stroke Syringes. These syringes help ensure volume regulation during fluid delivery, and are used for precise injection or withdrawal. All syringes are equipped with a dimple inside the barrel opposite the graduation, which acts as a plunger stop.

8 Jan 2014

Forest Laboratories enters into definitive agreement to acquire Aptalis

Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.

8 Jan 2014